Structure-based cheminformatics and molecular dynamics profiling of potential SIRT6 inhibitors
Molecular Diversity · 2025
DOI: 10.1007/s11030-025-11285-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Ali Al-Samydai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacological and Diagnostic Research Centre, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan. Hauptthemen laut MEDLINE: Sirtuins, Molecular Dynamics Simulation, Cheminformatics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Sirtuin-6 (SIRT6) is a NAD+-dependent deacetylase that maintains genome stability, metabolic regulation, and cellular stress responses, making it an attractive target for therapeutic intervention in metabolic and age-related diseases. Despite its biological importance, the identification of potent SIRT6 modulators remains limited. In this study, we applied an integrative computational approach combining cheminformatics, network pharmacology, molecular docking, and molecular dynamics simulations to explore new inhibitory candidates targeting SIRT6. A curated dataset of 78 CHEMBL compounds was used to develop robust multi-fingerprint QSAR models using Random Forest algorithms, validated through Y-randomization, external testing, and applicability domain analysis. Network pharmacology analysis revealed functional associations between SIRT6 and key regulatory proteins such as NAMPT, CD38, and HIF1A, highlighting its involvement in NAD⁺ biosynthesis and cellular stress pathways. Molecular docking identified CHEMBL50 (Quercetin) and CHEMBL4217987 as top candidates with favorable interactions at the SIRT6 catalytic site. These complexes were further evaluated through 200 ns MD simulations. Binding stability was confirmed using MM-GBSA free energy calculations, dynamic cross-correlation matrix (DCCM), and principal component analysis (PCA), demonstrating energetically favorable and stable protein-ligand interactions. Overall, this study offers a predictive and mechanistic framework for SIRT6 inhibitor discovery and provides lead scaffolds for further optimization and experimental validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacological and Diagnostic Research Centre, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Zarqa University, Zarqa, Jordan.
- Department of Pharmacy, Faculty of Health Sciences, American University of Madaba, Madaba, Jordan.
- Department of Pharmacy, Al-Manara College for Medical Sciences, Maysan, Iraq. amjadibrahim@uomanara.edu.iq.
- Department of Pharmacology, Collage of Pharmacy, Al-Nisour University College, Baghdad, Iraq.
- University of Maryland, Baltimore, USA.
Zitieren
APA
Al-Samydai, A., Al-Mamoori, F., Mayyas, A., Oraibi, A. I., Al-Hussaniy, H. A., Almukram, A., & Shakeel, F. (2025). Structure-based cheminformatics and molecular dynamics profiling of potential SIRT6 inhibitors. Molecular Diversity. https://doi.org/10.1007/s11030-025-11285-5
Vancouver
Al-Samydai A, Al-Mamoori F, Mayyas A, Oraibi AI, Al-Hussaniy HA, Almukram A, et al. Structure-based cheminformatics and molecular dynamics profiling of potential SIRT6 inhibitors. Molecular Diversity. 2025. doi:10.1007/s11030-025-11285-5
BibTeX
@article{AlSamydai2025,
author = {Al-Samydai, Ali and Al-Mamoori, Farah and Mayyas, Amal and Oraibi, Amjad Ibrahim and Al-Hussaniy, Hany Akeel and Almukram, Ali and Shakeel, Faiyaz},
title = {Structure-based cheminformatics and molecular dynamics profiling of potential SIRT6 inhibitors},
journal = {Molecular Diversity},
year = {2025},
doi = {10.1007/s11030-025-11285-5}
}
EUVIMED